Compounds > 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole
Page last updated: 2024-09-03

3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole and berotek

3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole has been researched along with berotek in 1 studies

Compound Research Comparison

Studies
(3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole)		Trials
(3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole)		Recent Studies (post-2010)
(3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole)		Studies
(berotek)		Trials
(berotek)		Recent Studies (post-2010) (berotek)
10331,786520111

Protein Interaction Comparison

ProteinTaxonomy3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole (IC50)berotek (IC50)
Beta-2 adrenergic receptorCavia porcellus (domestic guinea pig)0.06

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, HN; Chen, SC; Chin, YY; Chu, YT; Hung, CH; Kuo, CH; Lam, KP; Lee, MS; Tok, TS; Wang, WL1

Other Studies

1 other study(ies) available for 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole and berotek

ArticleYear
Inhibitory effects of albuterol and fenoterol on RANTES and IP-10 expression in bronchial epithelial cells.
    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2011, Volume: 22, Issue:4

    Topics: Albuterol; Asthma; Azides; Bronchi; Cell Line; Chemokine CCL5; Chemokine CXCL10; Cyclic AMP; Epithelial Cells; Fenoterol; Gene Expression Regulation; Humans; MAP Kinase Signaling System; Poly I-C; Propanolamines; Serotonin

2011